Tag: scottsdale 2 1

Tag: "scottsdale" at biology news

Scottsdale Healthcare, TGen announce strategic alliance

SCOTTSDALE Scottsdale Healthcare today announced a strategic alliance with the Translational Genomics Research Institute (TGen) in which Scottsdale Healthcare will become a primary clinical research site for TGen. ......Opening Oct. 24, the TGen Clinical Research Services (TCRS) will include a Genomics Medicine and Individual Therapy Center and a Pancreatic Cancer Center, and will be located in...

(Date:11/21/2009)... 20,2009 / b3c newswire / - KINAXO Biotechnologi...ound, gaining two new investors in the company, Le...eports that Jrgen Schumacher has been elected as a...NAXO shareholders Axel Ullrich, Hellmut Kirchner, ...al investors Mountain Partners, BioM, High-Tech Gr...

(Date:11/20/2009)...ed in the November 2009 issue of the journal GENE... how a family of genes (1-aminocyclopropane-1-carb...r production of ethylene. This gas affects many as...ays the foundation for future genetic manipulation... survive and thrive in difficult terrain, increase...

(Date:11/20/2009)...ments of plasma lipoprotein concentrations determi...R), researchers led by Daniel Chasman at Brigham a...Boston, MA, the Framingham Heart Study in Framingh...den and Oxford, England performed genetic associat...women of European ancestry from the Women,s Genome...

Breaking Biology News(10 mins):KINAXO Completes Financing Round to Enhance Biomarker Development 2 KINAXO Completes Financing Round to Enhance Biomarker Development 3 It's a gas: New discovery may lead to heartier, high-yielding plants 2 Genetic analysis helps dissect molecular basis of cardiovascular disease 2 The decision about the incision 3A Is midline or transverse better for abdominal surgery 3F 50399 1 The decision about the incision 3A Is midline or transverse better for abdominal surgery 3F 50399 2 A thirst for blood sparks toxic algal blooms 9065 1 A thirst for blood sparks toxic algal blooms 9065 2 Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial 50396 1 Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial 50396 2 Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial 50396 3 Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial 50396 4

[1] KINAXO Completes Financing Round to Enhance Biomarker Development [0] It's a gas: New discovery may lead to heartier, high-yielding plants [0] Genetic analysis helps dissect molecular basis of cardiovascular disease

Other Tagsstemming 2 exposed 2 exposed 3 exposed 4 exposed 5 exposed 6 exposed 7 exposed 8 exposed 9 exposed 10 data 2 data 3 data 4 data 5 data 6 data 7 data 8 data 9 data 10 care 2 care 3 care 4 care 5 care 6 care 7 care 8 care 9 care 10 style 2 done 2 done 3 done 4 done 5 done 6 done 7 done 8 done 9 done 10

prod stemming sorbent supelco accutane exposed data care style done maze simplified aboriginals insoles blast myelitis